Cash Flow Statement

Amortizatization of Intangibles Cash from Financing Activities Cash from Operations Change in Accured Expenses Change in Cash Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Other Working Capital Changes Other financing activities Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Ratios

Kairos Pharma (KAPA) Shares Issued (2025)

Kairos Pharma (KAPA) has disclosed Shares Issued for 1 consecutive years, with $3.1 million as the latest value for Q1 2025.